Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 010220

Expand all

HYPAQUE-M,75% (DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM)
50%;25%
Marketing Status: Discontinued

Active Ingredient: DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Proprietary Name: HYPAQUE-M,75%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 50%;25%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010220
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GE HEALTHCARE
Marketing Status:  Discontinued
Patent and Exclusivity Information

HYPAQUE-M,90% (DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM)
60%;30%
Marketing Status: Discontinued

Active Ingredient: DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Proprietary Name: HYPAQUE-M,90%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 60%;30%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N010220
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GE HEALTHCARE
Marketing Status:  Discontinued
Patent and Exclusivity Information